ASX:BGT
BIO-GENE TECHNOLOGY LTD
BIO-GENE TECHNOLOGY LTD has not announced any capital raises, but we are collecting interest for future raises.
< $50k
< 10
How Fresh Equities Works
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
Capital Raise History
Fresh Equities does not have BIO-GENE TECHNOLOGY LTD capital raise history data.
Company Overview
Bio-Gene Technology Ltd (BGT) is an Australian public biotechnology company that is developing a patent protected product platform as a new class of insecticides. Bio-Gene owns patents covering the use of these ?-triketone insecticides for insect control. Bio-Gene's is developing two products targeted at different sectors of the insecticide market. The natural product Qcide� is an oil extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana). This product is focused on organic insect control. FLAVOCIDE� is a chemically synthesised product developed as a nature identical molecule to molecules also found in Eucalyptus cloeziana extracts.
Type
Listed Company
GICS Sub-industry
Fertilizers & Agricultural Chemicals
Head Office
Level 12/575 Bourke St, Melbourne VIC 3000, Australia
Website
Quarterly Cash Flows
Fresh Equities does not have BIO-GENE TECHNOLOGY LTD quarterly cash flows data.
Directors
Fresh Equities does not have BIO-GENE TECHNOLOGY LTD directors data.
Announcements
Fresh Equities does not have BIO-GENE TECHNOLOGY LTD announcements data.
News
Fresh Equities does not have BIO-GENE TECHNOLOGY LTD news data.